Global brain glucose uptake on 18F-FDG-PET/CT is influenced by chronic cardiovascular risk

Abstract

Purpose:The goal of this study was to assess global cerebral glucose uptake in subjects with known cardiovascular risk factors by employing a quantitative 18 F-fluorodeoxyglucosepositron emission tomography/computed tomography (FDG-PET/CT) technique. We hypothesized that at-risk subjects would demonstrate decreased global brain glucose uptake compared to healthy controls. Methods:We compared 35 healthy male controls and 14 male subjects at increased risk for cardiovascular disease (CVD) as assessed by the Systematic Coronary Risk Evaluation tool. All subjects were grouped into two age-matched cohorts: younger (<50 years) and older (≥50 years). The global standardized uptake value mean (Avg SUVmean) was measured by mapping regions of interest (ROIs) of the entire brain across the supratentorial structures and cerebellum. Wilcoxon's rank-sum test was used to assess the differences in Avg SUVmean between controls and at-risk subjects.Results: Younger subjects demonstrated higher brain Avg SUVmean than older subjects.In addition, in both age strata, the 10-year risk for fatal cardiovascular disease according to the Systematic Coronary Risk Evaluation tool, was significantly greater in the at-risk groups than in healthy controls (younger: p=0.0304; older: p=0.0436). In the younger cohort, at-risk subjects demonstrated significantly lower brain Avg SUVmean than healthy controls (p=0.0355). In the older cohort, at-risk subjects similarly had lower Avg SUVmean than controls (p=0.0343). Conclusions:Global brain glucose uptake appears to be influenced by chronic cardiovascular risk factors. Therefore, FDG-PET/CT may play a role in determining the importance of CVD on brain function and its potential for monitoring the efficacy of various therapeutic interventions.

Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort study

“…These data confirm and expand on the results from a previous study on a small middle-aged cohort, 23 and on our cross-sectional findings in the same PESA cohort in which higher cardiovascular risk was associated with lower cerebral glucose metabolism. 11 They are also in line with reports from older longitudinal cohorts of cognitively intact individuals, 24 but go one step further by showing that the decline in cerebral glucose consumption starts earlier, during midlife.…”

Brain FDG PET for visualizing the relation between impaired lung function and cognitive decline in lung cancer: a preliminary study

“…Additionally, the patients with hypoxic COPD showed greater severity of cerebral hypoperfusion and cognitive decline than patients with non-hypoxic COPD or age-matched healthy participants; furthermore, hypoperfusion correlated with the results of neuropsychological tests [17]. Moreover, a recent study by Borja et al [18] reported that impaired blood flow to the brain causes a decrease in global brain glucose uptake on FDG PET/CT. Therefore, the reduction in brain glucose uptake in our study could be due to overall decreased blood flow rather than specific Alzheimer’s disease-like neurodegenerative changes.…”

A Critical Review of PET Tracers Used for Brain Tumor Imaging

“…The introduction of FDG in August 1976 opened a new era in medical imaging and has had a major impact on the management of many diseases and disorders over the past four decades (106). While early investigation demonstrated its role in neuropsychiatric disorders, over the years, this tracer has been shown to be effective in detecting a variety of common human diseases including cancer, inflammation, and metabolic abnormalities (107)(108)(109). Due to the lack of total-body PET imaging capabilities in the 1970s and 80s, most research studies that were conducted early on in the development of this modality dealt with brain disorders.…”